Your provider should: Evaluate your medical history and current health status Order baseline lab work (IGF-1, metabolic panel, hormones) Determine an appropriate starting dose Monitor your progress with follow-up labs and consultations Adjust your protocol based on your response Be proactive in communicating with your provider about your response, any side effects, and your treatment goals
Conclusion T2DM is a progressive disease and treatment intensification is often required to achieve and maintain glycemic control [1, 2]
Am J Kidney Dis 71(1):6574 Tonneijck L, Muskiet MHA, Smits MM, van Bommel EJ, Heerspink HJL, van Raalte DH et al (2017) Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
A favorable list decision can occur without the evidence package required for approval of a specific manufactured drug
PMID 37255614